Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Cancer of the Vulva

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Cancer of the Vulva in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blessing, JA; Homesley, HD; Lewis, GC; Thigpen, JT1

Trials

1 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Cancer of the Vulva

ArticleYear
Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study.
    Gynecologic oncology, 1986, Volume: 23, Issue:3

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Vulvar Neoplasms

1986